Shizuoka, Japan

Kanako Tatsumi

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 9.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: **Kanako Tatsumi: Pioneering Antigen-Binding Innovations in Shizuoka**

Introduction

Kanako Tatsumi is an accomplished inventor based in Shizuoka, Japan, recognized for her significant contributions in the field of immunology. With a total of four patents to her name, her innovative work focuses primarily on the development of anti-CD137 antigen-binding molecules. These advancements aim to provide effective treatments for various diseases while minimizing side effects on non-tumor tissues.

Latest Patents

Among her latest patents, Kanako Tatsumi has developed an Anti-CD137 antigen-binding molecule and its utilization. The objective of this groundbreaking disclosure is to create anti-CD137 antigen-binding molecules that possess immunocyte-activating effects, cytotoxic activity, and anti-tumor properties, while simultaneously having reduced effects on normal, non-tumor tissues. This innovation aims to produce less side effects for patients undergoing treatment. The patent also includes methods for using these molecules, alongside pharmaceutical formulations, highlighting their potential for safer therapeutic applications.

Moreover, she has contributed to the creation of antigen-binding molecules whose binding activity can vary depending on the concentration of small molecule compounds present in target tissues. This work includes the development of libraries of such antigen-binding molecules, providing a crucial tool for the target-specific treatment of various diseases.

Career Highlights

Kanako Tatsumi's professional journey has been significantly associated with Chugai Seiyaku Kabushiki Kaisha, a prominent company in the pharmaceutical industry. Her expertise and innovative mindset have led to substantial advancements in therapeutic technologies, particularly in the area of targeted cancer therapies through her research on antigen-binding molecules.

Collaborations

In her endeavors, Kanako Tatsumi has collaborated with talented colleagues such as Shun Shimizu and Shojiro Kadono. These partnerships foster a collaborative environment that enhances research capabilities and accelerates the development of innovative solutions in pharmaceuticals.

Conclusion

Kanako Tatsumi stands out as a leading inventor whose work has the potential to revolutionize cancer treatment methodologies. Her patents reflect her commitment to advancing scientific knowledge and providing effective therapies that target specific tissues, promising a future where pharmaceuticals can be both effective and safe. Her contributions will undoubtedly inspire future innovations in the field of immunology and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…